163 related articles for article (PubMed ID: 37171300)
1. Tislelizumab for squamous lung cancer combined with basal cell carcinoma of the skin: A case report.
Wu MJ; Chen YC; Cui XL; Yang Q; Xue QL
Medicine (Baltimore); 2023 May; 102(19):e33788. PubMed ID: 37171300
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma.
Zhao CY; Hwang SJE; Anforth R; Carlos G; Chou S; Carlino M; Fernández-Peñas P
J Immunother; 2018 Sep; 41(7):343-349. PubMed ID: 29939876
[TBL] [Abstract][Full Text] [Related]
3. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
[TBL] [Abstract][Full Text] [Related]
4. Rare basal cell metastasis of a basal-squamous skin collision tumour to the lung and axillary lymph node.
Li R; Lee G; Huang M; El-Sherief A
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31585957
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model.
Zhao M; Shao T; Chi Z; Tang W
Front Public Health; 2023; 11():1051484. PubMed ID: 36908446
[TBL] [Abstract][Full Text] [Related]
6. Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810.
Falchook GS; Leidner R; Stankevich E; Piening B; Bifulco C; Lowy I; Fury MG
J Immunother Cancer; 2016; 4():70. PubMed ID: 27879972
[TBL] [Abstract][Full Text] [Related]
7. Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma.
Mohan SV; Chang J; Li S; Henry AS; Wood DJ; Chang AL
JAMA Dermatol; 2016 May; 152(5):527-32. PubMed ID: 26914338
[TBL] [Abstract][Full Text] [Related]
8. Metastatic basal cell carcinoma: report of a case presenting with respiratory failure.
Degner RA; Kerley SW; McGregor DH; Dixon AY
Am J Med Sci; 1991 Jun; 301(6):395-7. PubMed ID: 2039026
[TBL] [Abstract][Full Text] [Related]
9. New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma.
Villani A; Potestio L; Fabbrocini G; Scalvenzi M
Adv Ther; 2022 Mar; 39(3):1164-1178. PubMed ID: 35089534
[TBL] [Abstract][Full Text] [Related]
10. Targeted Therapy and Immunotherapy in Nonmelanoma Skin Cancer.
Aboul-Fettouh N; Kubicki SL; Chen L; Silapunt S; Migden MR
Dermatol Clin; 2023 Jan; 41(1):23-37. PubMed ID: 36410980
[TBL] [Abstract][Full Text] [Related]
11. [Squamous cell carcinoma, basal cell carcinoma].
Ikeda S; Suzuki T; Kiyohara Y; Kuramochi A
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1293-301. PubMed ID: 7688499
[TBL] [Abstract][Full Text] [Related]
12. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
Ascierto PA; Schadendorf D
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
[TBL] [Abstract][Full Text] [Related]
13. [Squamous cell carcinoma and basal cell carcinoma].
Suzuki T; Inoue Y; Kuramochi A; Kiyohara Y; Ikeda S
Gan To Kagaku Ryoho; 1997 Jan; 24(1):16-22. PubMed ID: 9020940
[TBL] [Abstract][Full Text] [Related]
14. Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.
In GK; Nallagangula A; Choi JS; Tachiki L; Blackburn MJ; Capone S; Bollin KB; Reuben DY; Shirai K; Zhang-Nunes S; Ragab O; Terando A; Hu JC; Lee H; Bhatia S; Chandra S; Lutzky J; Gibney GT
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35545318
[TBL] [Abstract][Full Text] [Related]
15. Development of squamous cell carcinoma into basal cell carcinoma under treatment with Vismodegib.
Saintes C; Saint-Jean M; Brocard A; Peuvrel L; Renaut JJ; Khammari A; Quéreux G; Dréno B
J Eur Acad Dermatol Venereol; 2015 May; 29(5):1006-9. PubMed ID: 24980899
[TBL] [Abstract][Full Text] [Related]
16. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Stratigos AJ; Sekulic A; Peris K; Bechter O; Prey S; Kaatz M; Lewis KD; Basset-Seguin N; Chang ALS; Dalle S; Orland AF; Licitra L; Robert C; Ulrich C; Hauschild A; Migden MR; Dummer R; Li S; Yoo SY; Mohan K; Coates E; Jankovic V; Fiaschi N; Okoye E; Bassukas ID; Loquai C; De Giorgi V; Eroglu Z; Gutzmer R; Ulrich J; Puig S; Seebach F; Thurston G; Weinreich DM; Yancopoulos GD; Lowy I; Bowler T; Fury MG
Lancet Oncol; 2021 Jun; 22(6):848-857. PubMed ID: 34000246
[TBL] [Abstract][Full Text] [Related]
17. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
18. Cemiplimab in cutaneous squamous cell carcinomas (SCC): an overview and a clinical case.
Ghidini A; Santangelo D; Vaccaro G; Chillura M; Petrelli F
Oral Oncol; 2022 May; 128():105847. PubMed ID: 35367788
[TBL] [Abstract][Full Text] [Related]
19. [Cisplatin-based chemotherapy for advanced basal and squamous cell carcinomas].
Goldberg H; Tsalik M; Bernstein Z; Haim N
Harefuah; 1994 Oct; 127(7-8):217-21, 286. PubMed ID: 7813942
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma.
Yin VT; Pfeiffer ML; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2013; 29(2):87-92. PubMed ID: 23446297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
